MedPath

Spectroscopic Profiling of Extracellular Vesicles By Resonant Gold Nanostructures in the Infrared

Recruiting
Conditions
Vesicle
Interventions
Diagnostic Test: sierological test
Registration Number
NCT06266195
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

Extracellular vesicles, due to their ease of extraction and ability to represent the cells from which they originate, have high potential in the field of personalized medicine, especially in the identification of new early bio-markers of cancer, including hepatocellular carcinoma. Nevertheless, the development of high-throughput diagnostic methods in this area is still in its infancy, and the design of new integrated technological solutions is of great interest and topicality. The main hypothesis of this study is that the development of a novel technology integrating resonant gold nanostructures in the mid-infrared can significantly contribute to the development of new approaches for the diagnosis of hepatocellular carcinoma.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
GRUPPO HCCsierological test32 pazienti uomini o donne, con diagnosi di neoplasia primitiva del fegato
GRUPPO CIRROSIsierological test32 soggetti uomini o donne, \>18 anni con diagnosi di cirrosi epatica di differente eziologiA
Primary Outcome Measures
NameTimeMethod
primary endpoint12 months

To evaluate the change in extracellular vesicle concentration between the control group and oncology group. The concentration of vesicles per ml of blood will be measured by frequency shift of the plasmonic resonance peak of gold nanostructures following immuno-capture of vesicles.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

FPGemelliIRCCS

🇮🇹

Roma, Lazio, Italy

© Copyright 2025. All Rights Reserved by MedPath